Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca
The discovery of a new series of compounds that are potent, selective 5-HT<inf>2C</inf> receptor agonists is described herein as we continue our efforts to optimize the 2-phenylcyclopropylmethylamine scaffold. Modifications focused on the alkoxyl substituent present on the aromatic ring led to the identification of improved ligands with better potency at the 5-HT<inf>2C</inf> receptor and excellent selectivity against the 5-HT<inf>2A</inf> and 5-HT<inf>2B</inf> receptors. ADMET studies coupled with a behavioral test using the amphetamine-induced hyperactivity model identified four compounds possessing drug-like profiles and having antipsychotic properties. Compound (+)-16b, which displayed an EC<inf>50</inf> of 4.2 nM at 5-HT<inf>2C</inf>, no activity at 5-HT<inf>2B</inf>, and an 89-fold selectivity against 5-HT<inf>2A</inf>, is one of the most potent and selective 5-HT<inf>2C</inf> agonists reported to date. The likely binding mode of this series of compounds to the 5-HT<inf>2C</inf> receptor was also investigated in a modeling study, using optimized models incorporating the structures of β<inf>2</inf>-adrenergic receptor and 5-HT<inf>2B</inf> receptor.
Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents / J. Cheng, P.M. Giguère, O.K. Onajole, W. Lv, A. Gaisin, H. Gunosewoyo, C.M. Schmerberg, V.M. Pogorelov, R.M. Rodriguiz, G. Vistoli, W.C. Wetsel, B.L. Roth, A.P. Kozikowski. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 58:4(2015 Feb 26), pp. 1992-2002. [10.1021/jm5019274]
Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents
J. Cheng;P. M. Giguère;O. K. Onajole;W. Lv;A. Gaisin;H. Gunosewoyo;C. M. Schmerberg;V. M. Pogorelov;R. M. Rodriguiz;G. Vistoli;W. C. Wetsel;B. L. Roth;A. P. Kozikowski
2015
Abstract
The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is described herein as we continue our efforts to optimize the 2-phenylcyclopropylmethylamine scaffold. Modifications focused on the alkoxyl substituent present on the aromatic ring led to the identification of improved ligands with better potency at the 5-HT2C receptor and excellent selectivity against the 5-HT2A and 5-HT2B receptors. ADMET studies coupled with a behavioral test using the amphetamine-induced hyperactivity model identified four compounds possessing drug-like profiles and having antipsychotic properties. Compound (+)-16b, which displayed an EC50 of 4.2 nM at 5-HT2C, no activity at 5-HT2B, and an 89-fold selectivity against 5-HT2A, is one of the most potent and selective 5-HT2C agonists reported to date. The likely binding mode of this series of compounds to the 5-HT2C receptor was also investigated in a modeling study, using optimized models incorporating the structures of β2-adrenergic receptor and 5-HT2B receptor.
Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents / J. Cheng, P.M. Giguère, O.K. Onajole, W. Lv, A. Gaisin, H. Gunosewoyo, C.M. Schmerberg, V.M. Pogorelov, R.M. Rodriguiz, G. Vistoli, W.C. Wetsel, B.L. Roth, A.P. Kozikowski. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 58:4(2015 Feb 26), pp. 1992-2002. [10.1021/jm5019274]
none
Prodotti della ricerca::01 - Articolo su periodico
13
262
Article (author)
no
J. Cheng, P.M. Giguère, O.K. Onajole, W. Lv, A. Gaisin, H. Gunosewoyo, C.M. Schmerberg, V.M. Pogorelov, R.M. Rodriguiz, G. Vistoli, W.C. Wetsel, B.L. Roth, A.P. Kozikowski
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/425072
Citazioni
10
34
31
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
